{"id":424,"date":"2020-03-16T18:17:34","date_gmt":"2020-03-16T18:17:34","guid":{"rendered":"https:\/\/www.doctaforum-events.org\/2025\/translational-gecp2025\/?page_id=424"},"modified":"2025-07-01T07:05:35","modified_gmt":"2025-07-01T07:05:35","slug":"ver-programa","status":"publish","type":"page","link":"https:\/\/www.doctaforum-events.org\/2025\/translational-gecp2025\/ver-programa\/","title":{"rendered":"Ver Programa"},"content":{"rendered":"

<\/p>\n

\n
\n
\n
\n

10:30 – 10:45<\/h4>\n<\/div>\n
\n

Welcome<\/h4>\n<\/div>\n<\/div>\n
\n\n\n\n\t
<\/td>Dr. Mariano Provencio, <\/span>Hospital Univ. Puerta De Hierro, Majadahonda, Madrid<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n
\n
\n
\n

10:45 – 13:50<\/h4>\n<\/div>\n
\n

SESSION I – MOLECULAR ANALYSIS IN GECP STUDIES: REVENTION, ADJUVANT AND PERIOPERATIVE<\/h4>\n<\/div>\n<\/div>\n
\n\n\n\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t
Chairs<\/span><\/td>Dr. Jos\u00e9 Luis Gonz\u00e1lez Larriba, <\/span>Hospital Cl\u00ednico San Carlos, Madrid<\/span>
\nDr. Mariano Provencio, <\/span>Hospital Univ. Puerta De Hierro, Majadahonda, Madrid<\/span><\/td>\n<\/tr>\n
10:45 - 10:55<\/td>Residential radon and molecular alterations in non-small cell lung cancer<\/span>
\nDr. Virginia Calvo, <\/span>Hospital Univ. Puerta De Hierro, Majadahonda, Madrid<\/span><\/td>\n<\/tr>\n
10:55 - 11:15<\/td>NADIM adjuvant trial<\/span>
\nDr. Bartomeu Massuti, <\/span>Hospital General Univ. Dr. Balmis, Alicante<\/span><\/td>\n<\/tr>\n
11:15 - 11:30<\/td>Biomarker analysis of the NADIM adjuvant trial<\/span>
\nDr. Alberto Cruz, <\/span>Hospital Univ. Puerta De Hierro, Majadahonda, Madrid<\/span><\/td>\n<\/tr>\n
11:30 - 11:45<\/td>Tissue Matters: The envolving role of pathology in immunotherapy<\/span>
\nDr. Ignacio Wistuba, <\/span>Moffit Cancer Center, Florida, USA<\/span><\/td>\n<\/tr>\n
11:45 - 11:55<\/td>Predictive biomarkers for perioperative chemoimmunotherapy<\/span>
\nDr. Alberto Cruz, <\/span>Hospital Univ. Puerta De Hierro, Majadahonda, Madrid<\/span><\/td>\n<\/tr>\n
11:55 - 12:05<\/td>TCR repertoire as an emerging biomarker<\/span>
\nDr. Cristina Mart\u00ednez-Toledo, <\/span>Hospital Univ. Puerta De Hierro, Majadahonda, Madrid<\/span><\/td>\n<\/tr>\n
12:05 - 12:20<\/td>Role of neutrophil extracellular traps in tumor response to immunotherapy<\/span>
\nDr. Muhammad Shazad, <\/span>McGill University, Montreal, Canada<\/span><\/td>\n<\/tr>\n
12:20 - 12:50<\/td>Discussion<\/span><\/td>\n<\/tr>\n
12:50 - 13:10<\/td>Profiling cell identity and tissue architecture with single-cell and spatial transcriptomics<\/span>
\nDr. Linghua Wang, <\/span>University of Texas, MD Anderson Cancer Center in Houston, Texas, USA<\/span><\/td>\n<\/tr>\n
13:10 - 13:20<\/td>Mapping resistance: uncovering altered tumor pathways through spatial transcriptomics<\/span>
\nDr. Marta Molina, <\/span>Hospital Univ. Puerta De Hierro, Majadahonda, Madrid<\/span><\/td>\n<\/tr>\n
13:20 - 13:30<\/td>Single-cell resolution of peripheral immune remodeling by neoadjuvant chemoimmunotherapy in lung cancer<\/span>
\nDr. Juan Manuel Guti\u00e9rrez, <\/span>Hospital Univ. Puerta De Hierro, Majadahonda, Madrid<\/span><\/td>\n<\/tr>\n
13:30 - 13:50<\/td>Discussion<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n
\n
\n
\n

13:50 – 14:50<\/h4>\n<\/div>\n
\n

Lunch<\/h4>\n<\/div>\n<\/div>\n<\/div>\n
\n
\n
\n

14:50 – 15:40<\/h4>\n<\/div>\n
\n

SESSION II – TUMOR MICROENVIROMENT<\/h4>\n<\/div>\n<\/div>\n
\n\n\n\n\t\n\t\n\t\n\t\n\t
Chairs<\/span><\/td>Dr. Enric Carcereny, <\/span>ICO-Hospital Germans Trias i Pujol, Badalona, Barcelona<\/span>
\nDr. Manuel D\u00f3mine, <\/span>Hospital Univ. Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid<\/span><\/td>\n<\/tr>\n
14:50 - 15:05<\/td>BCR repertoire dynamics in tumor and blood reveal signatures of response to neoadjuvant chemoimmunotherapy<\/span>
\nDr. Bel\u00e9n Sierra, <\/span>Hospital Univ. Puerta De Hierro, Majadahonda, Madrid<\/span><\/td>\n<\/tr>\n
15:05 - 15:15<\/td>Neoadjuvant chemoimmunotherapy triggers TLS induction with distinct functional states in pathologic complete responders<\/span>
\nDr. \u00c1ngeles Gil-Gonzalez, <\/span>Hospital Univ. Puerta De Hierro, Majadahonda, Madrid<\/span><\/td>\n<\/tr>\n
15:15 - 15:25<\/td>Perioperative chemoimmunotherapy induces strong immune responses and long-term survival in patients with HLA class I-deficient non-small cell lung cancer<\/span>
\nDr. Marta Molina, <\/span>Hospital Univ. Puerta De Hierro, Majadahonda, Madrid<\/span><\/td>\n<\/tr>\n
15:25 - 15:40<\/td>Discussion<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n
\n
\n
\n

15:40 – 16:55<\/h4>\n<\/div>\n
\n

SESSION III – MICROBIOME<\/h4>\n<\/div>\n<\/div>\n
\n\n\n\n\t\n\t\n\t\n\t\n\t\n\t\n\t
Chairs<\/span><\/td>Dr. Paula Espinosa, <\/span>Hospital General Univ. de Valencia<\/span>
\nDr. Rosario Garc\u00eda Campelo, <\/span>Hospital Univ. de la Coru\u00f1a<\/span><\/td>\n<\/tr>\n
15:40 - 16:00<\/td>Beyond the tumor: The microbiome as a key player in immune modulation<\/span>
\nDr. Lisa Derosa, <\/span>Institut Gustave Roussy, Paris, France<\/span><\/td>\n<\/tr>\n
16:00 - 16:10<\/td>The Migrant trial<\/span>
\nDr. Rosa del Campo, <\/span>Hospital Univ. Ram\u00f3n y Cajal, Madrid<\/span><\/td>\n<\/tr>\n
16:10 - 16:20<\/td>Microbiome analysis in NADIM II trial<\/span>
\nDr. Alejandro Rodr\u00edguez, <\/span>Hospital Univ. Puerta De Hierro, Majadahonda, Madrid<\/span><\/td>\n<\/tr>\n
16:20 - 16:30<\/td>Metabolomic profiling reveals predictive biomarkers of response to perioperative chemoimmunotherapy in NSCLC<\/span>
\nDr. Atocha Romero, <\/span>Hospital Univ. Puerta De Hierro, Majadahonda, Madrid<\/span><\/td>\n<\/tr>\n
16:30 - 16:40<\/td>CUBIK trial biomarker study<\/span>
\nDr. Luc\u00eda Robado de Lope, <\/span>Hospital Univ. Puerta De Hierro, Majadahonda, Madrid<\/span><\/td>\n<\/tr>\n
16:40 - 16:55<\/td>Discussion<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n
\n
\n
\n

16:55 – 17:25<\/h4>\n<\/div>\n
\n

Coffee break<\/h4>\n<\/div>\n<\/div>\n<\/div>\n
\n
\n
\n

17:25 – 18:20<\/h4>\n<\/div>\n
\n

SESSION IV – ONGOING STUDY PROPOSALS WITH POSSIBLE COLLABORATION WITH GECP<\/h4>\n<\/div>\n<\/div>\n
\n\n\n\n\t\n\t\n\t\n\t\n\t\n\t
Chairs<\/span><\/td>Dr. Florentino Hernando Trancho, <\/span>Hospital Cl\u00ednico San Carlos, Madrid<\/span>
\nDr. Bartomeu Massuti, <\/span>Hospital General Univ. Dr. Balmis, Alicante<\/span><\/td>\n<\/tr>\n
17:25 - 17:35<\/td>Immuno Lung<\/span>
\nDr. Mar\u00eda Saigi, <\/span>ICO Badalona, Barcelona<\/span><\/td>\n<\/tr>\n
17:35 - 17:45<\/td>Epigenetic signature<\/span>
\nDr. Alejandro Olivares, <\/span>Hospital Cl\u00ednico Univ. de Salamanca<\/span><\/td>\n<\/tr>\n
17:45 - 17:55<\/td>Investigation of the microbiota in relation to the response to immunotherapy in patients affected by advanced non-small cell lung cancer<\/span>
\nDr. Juan Vicente Valor, <\/span>Hospital Cl\u00ednico San Carlos, Madrid<\/span><\/td>\n<\/tr>\n
17:55 - 18:05<\/td>Exploring galectin-1 as a new therapeutic target in small cell lung cancer (SCLC)<\/span>
\nDr. Arancha Cebri\u00e1n, <\/span>Hospital Univ. Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid<\/span><\/td>\n<\/tr>\n
18:05 - 18:20<\/td>Discussion<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n
\n
\n
\n

18:20 -18:40<\/h4>\n<\/div>\n
\n

SESSION V – PROFFERED POSTER<\/h4>\n<\/div>\n<\/div>\n
\n\n\n\n\t
<\/td>Poster review presenter: <\/span>
\nDr. Manuel Cobo, <\/span>Hospital Regional Univ. de M\u00e1laga<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n
\n
\n
\n

18:40<\/h4>\n<\/div>\n
\n

Closing remarks<\/h4>\n<\/div>\n<\/div>\n
\n\n\n\n\t
<\/td>Dr. Mariano Provencio, <\/span>Hospital Univ. Puerta De Hierro, Majadahonda, Madrid<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

10:30 – 10:45 Welcome 10:45 – 13:50 SESSION I – MOLECULAR ANALYSIS IN GECP STUDIES: REVENTION, ADJUVANT AND PERIOPERATIVE 13:50 – 14:50 Lunch 14:50 – 15:40 SESSION II – TUMOR MICROENVIROMENT 15:40 – 16:55 SESSION III – MICROBIOME 16:55 – 17:25 Coffee break 17:25 – 18:20 SESSION IV – ONGOING STUDY PROPOSALS WITH POSSIBLE COLLABORATION […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-424","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.doctaforum-events.org\/2025\/translational-gecp2025\/wp-json\/wp\/v2\/pages\/424","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.doctaforum-events.org\/2025\/translational-gecp2025\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.doctaforum-events.org\/2025\/translational-gecp2025\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.doctaforum-events.org\/2025\/translational-gecp2025\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.doctaforum-events.org\/2025\/translational-gecp2025\/wp-json\/wp\/v2\/comments?post=424"}],"version-history":[{"count":85,"href":"https:\/\/www.doctaforum-events.org\/2025\/translational-gecp2025\/wp-json\/wp\/v2\/pages\/424\/revisions"}],"predecessor-version":[{"id":1453,"href":"https:\/\/www.doctaforum-events.org\/2025\/translational-gecp2025\/wp-json\/wp\/v2\/pages\/424\/revisions\/1453"}],"wp:attachment":[{"href":"https:\/\/www.doctaforum-events.org\/2025\/translational-gecp2025\/wp-json\/wp\/v2\/media?parent=424"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}